Cryptococcal IRIS is thought to be the result of patients developing a new C. neoformans infection (relapsing) or the reactivation of a latent or sub-clinical infection following anti-viral therapy, which in turn activates pathologic CD4+ T-cell mediated immune responses to fungal antigens [3]. Here, CD4 is linked to infection.